Question 1 of 4
Do you confirm that you are a parent or guardian of a potential study participant and you are 18 years of age or older?
Question 2 of 4
Is the child or teen between 6 and 17 years of age?
Question 3 of 4
Does the child or teen currently have at least 1 of the following signs or symptoms of COVID-19 and did their symptoms start within the last 5 days?
Question 4 of 4
Does the child or teen have at least 1 characteristic or underlying medical condition that puts them at high risk of developing severe illness from COVID-19?

So far - So good!

You appear to meet the basic requirements for this COVID-19 study. However, only the research study staff can determine if you qualify to enroll. Please enter your contact information and select "Find a Site" to see if there is a study site enrolling in your area. To be eligible, you need to make an appointment as soon as possible and within 5 days of COVID-19 sign/symptom onset.

Choose a Location
Please select a research site near you. If you don't see a site near you, then select "The sites listed here are not convenient for me." Study locations are being added regularly. A study representative will call you if a research site becomes available in your area.

Arkansas Children's Hospital (English only)

1 Children's Way
Little Rock, Arkansas 72202
NaN Mi

Avera Health

6001 S Sharon Ave, Suite 2
Sioux Falls, South Dakota 57108
NaN Mi

Biopharma Informatic INC (English and Espanol)

19255 Park Row
Houston, Texas 77084
NaN Mi

Biopharma Informatic, LLC (English and Espanol)

1200 E. Ridge Rd.
McAllen, Texas 78503
NaN Mi

Biopharma Informatics Inc (English and Espanol)

25311 Kingsland Blvd., Suite 190
Katy, Texas 77494
NaN Mi

Children's Healthcare of Atlanta Center for Advanced Pediatrics (English and Espanol)

1400 Tullie Road, NE
Atlanta, Georgia 30329
NaN Mi

Columbia University Irving Medical Center, HP6 - Rm 604 (English and Espanol)

180 Fort Washington Avenue
New York, New York 10032
NaN Mi

The sites listed here are not convenient for me.

Sorry, you are not eligible at this time...

Thank you for your interest in this COVID-19 study and for answering our questions. We encourage you to enter your information below if you would like to be contacted about future clinical research opportunities. Contact your healthcare provider if you have any medical questions.

First name must not be blank

Last name must not be blank

Please enter a valid phone number

Please enter a valid email

Please select a valid address


This study is evaluating the safety and effectiveness of Paxlovid, a possible oral treatment for COVID-19 in children and teens. If the child or teen has an underlying medical condition and has at least one sign/symptom of COVID-19, or has been recently diagnosed with COVID-19, this study may be an option.

Who May Participate

Joining a clinical trial is an important and personal decision. Thank you for considering this study. This study may be an option for children and teens who are:


6 to 17 years of age


Having at least one sign/symptom of COVID-19:

  • Cough
  • Shortness of breath or difficulty breathing
  • Fever (documented temperature > 38C (100.4F) or feeling feverish)
  • Chills or shivering
  • Fatigue (low energy or tiredness)
  • Muscle or body aches
  • Diarrhea (loose or watery stools)
  • Vomiting (throwing up)
  • Nausea (feeling like you want to throw up)
  • Headache
  • Sore throat
  • Stuffy or runny nose

Children must be able to swallow tablets and must meet weight requirements.


Having at least 1 of the following characteristics or underlying medical conditions that puts them at risk for severe illness:

  • Immunosuppressive disease (i.e. cancer treatment, HIV, autoimmune disorders)
  • Chronic lung, heart, or kidney disease
  • Sickle cell disease
  • Hypertension (high blood pressure)
  • Active cancer (other than skin cancer)
  • Type 1 or Type 2 diabetes
  • Neurodevelopmental disorder (i.e. cerebral palsy, Downs syndrome)
  • Overweight or obese
  • Current smoker

Note: There are other requirements to participate in this study. A study team member will help determine if this study is right for your family.

top of section

What To Expect


All participants will receive the study medicine, Paxlovid, which is taken orally twice a day for 5 days (10 total doses).


The child or teen's participation in the study will last about 5 weeks.


Over the course of 5 weeks, they will need to attend at least 8 study visits. These may include a combination of in-person visits at the clinic or your home, or remote visits over the telephone or computer.

Teen Writing on Couch
Pfizer Logo